Biomarin Pharmaceutical reported $186K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31343M 96M
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
Insmed INSM:US $ 1.2M 6K
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Moderna Inc MRNA:US 39.2K 800
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sangamo Biosciences SGMO:US $ 1.53M 0.07M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M
YTE INCY:US $ 0.22M 0M